SCHEMBL30858715

SCHEMBL30858715

COC(=O)[C@@H]1C[C@@H](NC(=O)OCc2ccccc2)CN1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPB1 P15086 1/20 0.55
ALDH1A1 P00352 3/20 0.53
GAA P10253 1/20 0.53
TSHR P16473 3/20 0.51
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP1A2 P05177 1/20 0.48
POLB P06746 1/20 0.48
CYP2D6 P10635 1/20 0.48
EPHX1 P07099 1/20 0.48
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
ACHE P22303 2/20 0.47
CTSL P07711 1/20 0.46
CTSB P07858 1/20 0.46
CTSK P43235 1/20 0.46
TLR4 O00206 1/20 0.46
NAAA Q02083 1/20 0.46
KDM1A O60341 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12583744 1.00 CPB1 (0.55) CPB1ALDH1A1GAATSHRCYP2C9
SCHEMBL489210 1.00 CPB1 (0.55) CPB1ALDH1A1GAATSHRCYP2C9
SCHEMBL30736153 0.83 ALDH1A1 (0.56) CPB1ALDH1A1GAATSHRCYP2C9
Hydrochloric Acid SCHEMBL9269780 0.82 ALDH1A1 (0.55) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL31000543 0.82 CPB1 (0.48) CPB1ALDH1A1GAATSHRCYP2C9
SCHEMBL13275989 0.82 ALDH1A1 (0.64) CPB1ALDH1A1GAATSHRCYP2C9
SCHEMBL12525124 0.82 ALDH1A1 (0.64) CPB1ALDH1A1GAATSHRCYP2C9
SCHEMBL12479923 0.80 KMT2A (0.45) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL12836421 0.80 ALDH1A1 (0.55) CPB1ALDH1A1GAATSHREPHX1
SCHEMBL12836420 0.80 ALDH1A1 (0.55) CPB1ALDH1A1GAATSHREPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4618952-A2 METHODS FOR TREATING OBESITY WITH AN MC4R AGONIST Rhythm Pharmaceuticals, Inc. (US) 2025-09-24 EP disclosed
WO-2024108198-A2 METHODS OF TREATING OBESITY WITH AN MC4R AGONIST RHYTHM PHARMACEUTICALS, INC. (US) 2024-05-23 WO disclosed